Differences in Cardiometabolic Risk between Insulin-Sensitive and Insulin-Resistant Overweight and Obese Children

Childhood Obesity
Unab I KhanJudith Wylie-Rosett

Abstract

It is known that 15-30% overweight/obese adults do not suffer cardiometabolic consequences. There is limited literature examining factors that can be used to assess cardiometabolic health in overweight/obese children. If such factors can be identified, they would aid in differentiating those most in need for aggressive management. Baseline data from 7- to 12-year-old, overweight, and obese children enrolled in a weight management program at an urban hospital were analyzed. Homeostatic model assessment for insulin resistance (HOMA-IR) <2.6 was used to define insulin-sensitive and HOMA-IR ≥2.6 was used to defined insulin-resistant participants. Demographics, physical activity measures, and cardiometabolic risk factors were compared between the two phenotypes. Odds ratios (ORs) examining the association between intermediate endpoints (metabolic syndrome [MetS], nonalcoholic fatty liver disease [NAFLD], systemic inflammation, and microalbuminuria) and the two metabolic phenotypes were evaluated. Of the 362 overweight/obese participants, 157 (43.5%) were insulin sensitive and 204 (56.5%) were insulin resistant. Compared to the insulin-sensitive group, the insulin-resistant group was older (8.6±1.6 vs. 9.9±1.7; p<0.001) and had a hig...Continue Reading

Associated Clinical Trials

References

Mar 1, 1976·Archives of Disease in Childhood·J M Tanner, R H Whitehouse
Jul 1, 1991·The Journal of Clinical Investigation·B A SwinburnE Ravussin
May 20, 1998·Medicine and Science in Sports and Exercise·P S FreedsonJ Sirard
Feb 24, 2001·Diabetes Care·D G MarreroS Garfield
Jun 27, 2002·Vascular Medicine·Jay P Garg, George L Bakris
Aug 10, 2002·American Journal of Physiology. Endocrinology and Metabolism·Gianluca PerseghinLivio Luzi
Jan 15, 2004·The Journal of Pediatrics·Neslihan GungorSilva Arslanian
Aug 3, 2004·Pediatrics·UNKNOWN National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents
Nov 4, 2004·The Journal of Clinical Endocrinology and Metabolism·Catherine W YeckelSonia Caprio
Dec 17, 2004·The New England Journal of Medicine·Jennifer K PaiEric B Rimm
Mar 31, 2005·The Journal of Clinical Endocrinology and Metabolism·Ram WeissSonia Caprio
Apr 28, 2005·The Journal of Clinical Endocrinology and Metabolism·Antony D KarelisRemi Rabasa-Lhoret
Dec 6, 2005·Metabolism: Clinical and Experimental·Thomas ReinehrRanier Wunsch
May 27, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Markus JuonalaOlli T Raitakari
Jun 1, 2006·The Journal of Clinical Endocrinology and Metabolism·James B MeigsRalph B D'Agostino
Oct 4, 2006·Pediatrics·Jeffrey B SchwimmerCynthia Behling
Sep 14, 2007·Pediatric Diabetes·Valeria HirschlerMauricio Jadzinsky
Feb 15, 2008·Diabetes Care·Ram Weiss, Francine Ratner Kaufman
Mar 25, 2008·Journal of Clinical Epidemiology·Crystal Man Ying LeeMark Woodward
Jul 9, 2008·Journal of Pediatric Gastroenterology and Nutrition·Fatih DemircioğluAlparslan Tuncel Sedat
Aug 13, 2008·Archives of Internal Medicine·Norbert StefanHans-Ulrich Häring
Oct 2, 2009·Journal of Endocrinological Investigation·S PiliaS Loche
Aug 31, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nicola SantoroSonia Caprio
Jan 14, 2011·Diabetes Care·UNKNOWN American Diabetes Association
Jan 18, 2012·JPEN. Journal of Parenteral and Enteral Nutrition·Frank R Sinatra
Feb 1, 2013·Journal of Clinical Research in Pediatric Endocrinology·Özgür PirgonBumin Nuri Dündar
Aug 14, 2013·Pediatrics·Mark D DeboerMatthew J Gurka

❮ Previous
Next ❯

Citations

Aug 30, 2018·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S DamanhouryG D C Ball
Feb 27, 2021·Journal of Pediatric Gastroenterology and Nutrition·Ana Pilar Nso-RocaFrancisco Sánchez Ferrer

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Software Mentioned

Stata

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.